CAMP-regulated Guanine Nucleotide Exchange Factor II (Epac2) Mediates Ca2+-induced Ca2+ Release in INS-1 Pancreatic Beta-cells
Overview
Authors
Affiliations
1. The signal transduction pathway responsible for cAMP-dependent Ca2+-induced Ca2+ release (CICR) from endoplasmic reticulum Ca2+ stores was assessed in the insulin-secreting cell line INS-1. 2. CICR was triggered by the GLP-1 receptor agonist exendin-4, an effect mimicked by caffeine, Sp-cAMPS or forskolin. CICR required influx of Ca2+ through L-type voltage-dependent Ca2+ channels, and was blocked by treatment with nimodipine, thapsigargin, or ryanodine, but not by the IP3 receptor antagonist xestospongin C. 3. Treatment with the cAMP antagonist 8-Br-Rp-cAMPS blocked CICR in response to exendin-4, whereas the PKA inhibitor H-89 was ineffective when tested at a concentration demonstrated to inhibit PKA-dependent gene expression. 4. RT-PCR of INS-1 cells demonstrated expression of mRNA coding for the type-II isoform of cAMP-regulated guanine nucleotide exchange factor (cAMP-GEF-II, Epac2). 5. CICR in response to forskolin was blocked by transient transfection and expression of a dominant negative mutant isoform of cAMP-GEF-II in which inactivating mutations were introduced into the exchange factor's two cAMP-binding domains. 6. It is concluded that CICR in INS-1 cells results from GLP-1 receptor-mediated sensitization of the intracellular Ca2+ release mechanism, a signal transduction pathway independent of PKA, but which requires cAMP-GEF-II.
Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease.
Sangwung P, Ho J, Siddall T, Lin J, Tomas A, Jones B Am J Physiol Endocrinol Metab. 2024; 327(5):E600-E615.
PMID: 38984948 PMC: 11559640. DOI: 10.1152/ajpendo.00371.2023.
Moon J, Choe H, Lim S J Diabetes Investig. 2024; 15(6):669-683.
PMID: 38676410 PMC: 11143426. DOI: 10.1111/jdi.14221.
Klemen M, Dolensek J, Krizancic Bombek L, Pohorec V, Gosak M, Rupnik M Front Endocrinol (Lausanne). 2023; 14:1225486.
PMID: 37701894 PMC: 10494243. DOI: 10.3389/fendo.2023.1225486.
GLP-1R Signaling and Functional Molecules in Incretin Therapy.
Wan W, Qin Q, Xie L, Zhang H, Wu F, Stevens R Molecules. 2023; 28(2).
PMID: 36677809 PMC: 9866634. DOI: 10.3390/molecules28020751.
Inoue R, Tsuno T, Togashi Y, Okuyama T, Sato A, Nishiyama K iScience. 2022; 25(7):104603.
PMID: 35800776 PMC: 9253497. DOI: 10.1016/j.isci.2022.104603.